New strategies to improve clinical outcomes for diabetic kidney disease

• Published in: BMC medicine Vol. 20; no. 1; pp. 1 - 15
• Main Authors: Forst, Thomas, Mathieu, Chantal, Giorgino, Francesco, Wheeler, David C., Papanas, Nikolaos, Schmieder, Roland E., Halabi, Atef, Schnell, Oliver, Streckbein, Marina, Tuttle, Katherine R.
• Format: Journal Article
• Language: English
• Published: London BioMed Central Ltd 10.10.2022; BioMed Central; BMC
• Subjects: Blood pressure; Cardiovascular disease; Care and treatment; Cholesterol; Clinical outcomes; Clinical trials; Creatinine; Diabetes; Diabetes mellitus; Diabetes mellitus (non-insulin dependent); Diabetic kidney disease; Diabetic nephropathies; Diabetic nephropathy; Diagnosis; End-stage renal disease; Glomerular filtration rate; Glucose; Health services; Hemodialysis; Hypertension; Kidney diseases; Kidney protective agents; Kidneys; Mortality; Pathophysiology; Reagents; Renal failure; Review; Risk factors; Transplants & implants; Type 2 diabetes; United States

Background Diabetic kidney disease (DKD), the most common cause of kidney failure and end-stage kidney disease worldwide, will develop in almost half of all people with type 2 diabetes. With the incidence of type 2 diabetes continuing to increase, early detection and management of DKD is of great cl...